These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24327435)

  • 1. Radiolabeled antagonistic bombesin peptidomimetics for tumor targeting.
    Valverde IE; Huxol E; Mindt TL
    J Labelled Comp Radiopharm; 2014 Apr; 57(4):275-8. PubMed ID: 24327435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing the Backbone Function of Tumor Targeting Peptides by an Amide-to-Triazole Substitution Strategy.
    Valverde IE; Vomstein S; Fischer CA; Mascarin A; Mindt TL
    J Med Chem; 2015 Sep; 58(18):7475-84. PubMed ID: 26309061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amide-to-triazole switch vs. in vivo NEP-inhibition approaches to promote radiopeptide targeting of GRPR-positive tumors.
    Maina T; Kaloudi A; Valverde IE; Mindt TL; Nock BA
    Nucl Med Biol; 2017 Sep; 52():57-62. PubMed ID: 28636973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical pharmacokinetic, biodistribution, imaging and therapeutic efficacy of (177)Lu-Labeled glycated bombesin analogue for gastrin-releasing peptide receptor-positive prostate tumor targeting.
    Lim JC; Cho EH; Kim JJ; Choi SM; Lee SY; Nam SS; Park UJ; Park SH
    Nucl Med Biol; 2015 Mar; 42(3):234-41. PubMed ID: 25498002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer.
    Richter S; Wuest M; Krieger SS; Rogers BE; Friebe M; Bergmann R; Wuest F
    Nucl Med Biol; 2013 Nov; 40(8):1025-34. PubMed ID: 23969085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel radiolabeled peptides for breast and prostate tumor PET imaging: (64)Cu/and (68)Ga/NOTA-PEG-[D-Tyr(6),βAla(11),Thi(13),Nle(14)]BBN(6-14).
    Fournier P; Dumulon-Perreault V; Ait-Mohand S; Tremblay S; Bénard F; Lecomte R; Guérin B
    Bioconjug Chem; 2012 Aug; 23(8):1687-93. PubMed ID: 22770480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET of tumors expressing gastrin-releasing peptide receptor with an 18F-labeled bombesin analog.
    Dijkgraaf I; Franssen GM; McBride WJ; D'Souza CA; Laverman P; Smith CJ; Goldenberg DM; Oyen WJ; Boerman OC
    J Nucl Med; 2012 Jun; 53(6):947-52. PubMed ID: 22570329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated bombesin-based radioantagonist for the labeling with single-photon emission computed tomography, positron emission tomography, and therapeutic radionuclides.
    Mansi R; Wang X; Forrer F; Kneifel S; Tamma ML; Waser B; Cescato R; Reubi JC; Maecke HR
    Clin Cancer Res; 2009 Aug; 15(16):5240-9. PubMed ID: 19671861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next Step toward Optimization of GRP Receptor Avidities: Determination of the Minimal Distance between BBN(7-14) Units in Peptide Homodimers.
    Fischer G; Lindner S; Litau S; Schirrmacher R; Wängler B; Wängler C
    Bioconjug Chem; 2015 Aug; 26(8):1479-83. PubMed ID: 26200324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrin releasing peptide receptor-directed radioligands based on a bombesin antagonist: synthesis, (111)in-labeling, and preclinical profile.
    Marsouvanidis PJ; Nock BA; Hajjaj B; Fehrentz JA; Brunel L; M'Kadmi C; van der Graaf L; Krenning EP; Maina T; Martinez J; de Jong M
    J Med Chem; 2013 Mar; 56(6):2374-84. PubMed ID: 23427837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel glycated [99mTc(CO)3]-labeled bombesin analogues for improved targeting of gastrin-releasing peptide receptor-positive tumors.
    Schweinsberg C; Maes V; Brans L; Bläuenstein P; Tourwé DA; Schubiger PA; Schibli R; García Garayoa E
    Bioconjug Chem; 2008 Dec; 19(12):2432-9. PubMed ID: 19053304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1,2,3-Triazole Stabilized Neurotensin-Based Radiopeptidomimetics for Improved Tumor Targeting.
    Mascarin A; Valverde IE; Vomstein S; Mindt TL
    Bioconjug Chem; 2015 Oct; 26(10):2143-52. PubMed ID: 26347939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging.
    Pan D; Xu YP; Yang RH; Wang L; Chen F; Luo S; Yang M; Yan Y
    Amino Acids; 2014 Jun; 46(6):1481-9. PubMed ID: 24633452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a new bombesin analog radiolabeled with lutetium-177: in vivo evaluation of the biological properties in Balb-C mice.
    Pujatti PB; Santos JS; Massicano AV; Mengatti J; De Araújo EB
    Cell Mol Biol (Noisy-le-grand); 2010 May; 56(2):18-24. PubMed ID: 20525454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of 64Cu-labeled bifunctional chelate-bombesin conjugates.
    Ait-Mohand S; Fournier P; Dumulon-Perreault V; Kiefer GE; Jurek P; Ferreira CL; Bénard F; Guérin B
    Bioconjug Chem; 2011 Aug; 22(8):1729-35. PubMed ID: 21761921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel series of (177)Lu-labeled bombesin derivatives with amino acidic spacers for selective targeting of human PC-3 prostate tumor cells.
    Pujatti PB; Santos JS; Couto RM; Melero LT; Suzuki MF; Soares CR; Grallert SR; Mengatti J; De Araújo EB
    Q J Nucl Med Mol Imaging; 2011 Jun; 55(3):310-23. PubMed ID: 21532543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of Radiolabeled Analogs of Minigastrin by Multiple Amide-to-Triazole Substitutions.
    Grob NM; Schmid S; Schibli R; Behe M; Mindt TL
    J Med Chem; 2020 May; 63(9):4496-4505. PubMed ID: 32302130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study on DOTA-derivatized bombesin analog labeled with 90Y and 177Lu: in vitro and in vivo evaluation.
    Koumarianou E; Mikołajczak R; Pawlak D; Zikos X; Bouziotis P; Garnuszek P; Karczmarczyk U; Maurin M; Archimandritis SC
    Nucl Med Biol; 2009 Aug; 36(6):591-603. PubMed ID: 19647165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of bombesin derivatives on the basis of pan-bombesin peptides labeled with indium-111, lutetium-177, and yttrium-90 for targeting bombesin receptor-expressing tumors.
    Zhang H; Chen J; Waldherr C; Hinni K; Waser B; Reubi JC; Maecke HR
    Cancer Res; 2004 Sep; 64(18):6707-15. PubMed ID: 15374988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 177Lu-labeled RGD-BBN heterodimeric peptide for targeting prostate carcinoma.
    Jiang L; Miao Z; Liu H; Ren G; Bao A; Cutler CS; Shi H; Cheng Z
    Nucl Med Commun; 2013 Sep; 34(9):909-14. PubMed ID: 23708872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.